Abstract:Clonorchis sinensis ( C. sinensis ) infection plays an important role in the progression of hepatocarcinogenesis. However, its specific role in HCC progression remains unclear. This study aimed to investigate whether C. sinensis contributes to angiogenesis in HCC. A comprehensive clinical analysis was conducted on 947 HCC patients, divided into two groups: C . sinensis (-) HCC and C . sinensis (+) HCC. Kaplan–Meier survival curves and log-rank tests were utilized to assess survival outcomes. Microvessel density (MVD) was evaluated through CD34 immunohistochemistry on hepatectomy specimens. A chemistry analyzer and blood analyzer were employed to measure the concentration of circulating angiogenesis-related biomarkers. Quantitative reverse transcription-PCR (qRT-PCR) was used to analyze the expression of angiogenesis-related genes (CD34, Ang1, Ang2, VEGF, PDGF) in HCC tissues. C . sinensis infection was associated with poorer outcomes in HCC patients, with significantly shorter overall survival (OS) ( p = 0.014) and recurrence-free survival (RFS) ( p <0.001). Notably, C . sinensis infection led to an upregulation of MVD in HCC tissues ( p = 0.041). C . sinensis (+) HCC patients exhibited significantly higher levels of circulating angiogenesis-related biomarkers, including MONO ( p = 0.004), EOSO ( p < 0.001), C3 ( p = 0.001), FIB ( p = 0.010), PLT ( p = 0.003), LDH ( p = 0.004), GLDH ( p = 0.003), compared to C . sinensis (-) HCC patients. Moreover, qRT-PCR analysis revealed that most angiogenesis-related genes were overexpressed in patients with C . sinensis infection. C . sinensis infection is closely associated with inflammatory responses and may promote metabolic reprogramming in HCC, thereby enhancing its malignant characteristics. Clonorchis sinensis ( C . sinensis ) is a prominent food-borne parasite prevalent in regions such as China, particularly in Guangxi. C . sinensis is classified as a class I carcinogen by the International Agency for Research on Cancer for cholangiocarcinoma. Recently, C . sinensis has also been linked to poor prognosis in hepatocellular carcinoma (HCC) patients. However, the mechanisms through which C . sinensis infection influences HCC progression, particularly through angiogenesis, are not well understood. In this study, we analyzed clinical data from 947 HCC patients, comparing those with and without C . sinensis infection. Our findings confirmed that C . sinensis infection was associated with shorter survival outcomes. Furthermore, C . sinensis (+) HCC patients exhibited significantly higher rates of metastasis and MVI compared to C . sinensis (-) HCC patients. Notably, C . sinensis infection led to an upregulation of microvessel density (MVD) in HCC tissues. Additionally, C . sinensis (+) HCC patients exhibited significantly higher levels of circulating angiogenesis-related biomarkers and overexpression of angiogenesis-related genes. These results suggest that C . sinensis may promote HCC progression by inducing angiogenesis. Our study sheds new light on the carcinogenic potential of C . sinensis and highlights the potential of anti-angiogenic therapies as a promising approach to improve outcomes for HCC patients with C . sinensis infection.

Genomic Characteristics, Metabolic Signature and Immune Microenvironment of Clonorchis Sinensis-Related Intrahepatic Cholangiocarcinoma

FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma

Clonorchis sinensis infection contributes to hepatocellular carcinoma progression via enhancing angiogenesis

Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis

Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma

Multi-omics-driven Discovery of Invasive Patterns and Treatment Strategies in CA19-9 Positive Intrahepatic Cholangiocarcinoma

Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis

Immune Cell Atlas of Cholangiocarcinomas Reveals Distinct Tumor Microenvironments and Associated Prognoses.

Extracellular vesicles of Clonorchis sinensis promote the malignant phenotypes of cholangiocarcinoma via NF-κB/EMT axis

Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma

The Clinical Implications and Molecular Features of Intrahepatic Cholangiocarcinoma with Perineural Invasion.

Abstract LT09: Integrative Multi-Omics Enhancer Activity Profiling Identifies Therapeutic Vulnerabilities in Cholangiocarcinoma of Different Etiologies

Comprehensive Molecular Profiling of Intrahepatic Cholangiocarcinoma in the Chinese Population and Therapeutic Experience

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Transcriptomic Profiling Reveals Hepatic Stem-Like Gene Signatures and Interplay of Mir-200C and Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma.

The Global Epidemiology of Clonorchiasis and Its Relation with Cholangiocarcinoma.

csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis

Multiple Cellular Origins and Molecular Evolution of Intrahepatic Cholangiocarcinoma

Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Patients